πŸ‡ΊπŸ‡Έ FDA
Patent

US 7892755

Screening method

granted A61PA61P1/00A61P3/04

Quick answer

US patent 7892755 (Screening method) held by Takeda Pharmaceutical Company Limited expires Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Feb 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61P, A61P1/00, A61P3/04, A61P3/10, A61P35/00